tebentafusp-tebn
immunocore
['tebentafusp', 'melanoma']
#cedarssinaicancer at #aacr23. dr. omid hamid is co-author on the poster long-term survival follow-up of #tebentafusp in previously treated metastatic uveal #melanoma (mum) being presented at 6:00am pt. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.